One shot for two viruses? new combo mRNA vaccine tested
NCT ID NCT06680375
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This early-stage study tested a new mRNA vaccine that aims to protect against both the flu and COVID-19 in a single shot. Researchers gave the vaccine to 106 healthy adults aged 18-64 to check for side effects and measure immune responses. The goal is to see if combining these vaccines is safe and effective enough to move into larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Anniston, Alabama, 36207, United States
-
GSK Investigational Site
Rolling Hills Estates, California, 90274, United States
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
Miami, Florida, 33147, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
St Louis, Missouri, 63141, United States
-
GSK Investigational Site
Omaha, Nebraska, 68134, United States
-
GSK Investigational Site
Rochester, New York, 14609, United States
Conditions
Explore the condition pages connected to this study.